Duke Medical Center

Andrew Nixon, Ph.D./MBA, is Professor of Medicine and Director of the Phase I Biomarker Laboratory at Duke University. He is a nationally recognized expert regarding the development of biomarkers, bringing extensive experience in coordinating multi-investigator and multi-center correlative analyses to the ACCRU network. Dr Nixon joined the ACCRU Board of Directors in 2019 and serves as the Translational and Correlative Science advisor.